Latest news with #StaceyKennedy
Associated Press
12 hours ago
- Business
- Associated Press
Americans to Corporate America: Step Up, Get Local, and Lead with Your Values
STAMFORD, Conn.--(BUSINESS WIRE)--Jun 11, 2025-- A groundbreaking new survey, 'Invested in America: Today's High Standards for U.S. Companies,' released today on behalf of Philip Morris International's U.S. businesses ('PMI U.S.'), reveals that the majority of Americans expect corporations to take a leading role in addressing community and societal challenges—favoring local impact. The PMI U.S. Philanthropy 2025 Benchmark Survey, conducted in April among 1,000 U.S. adults aged 21+, offers a portrait of a public that wants companies to go beyond business as usual. Companies are viewed as powerful and potentially better equipped than the government to drive change but only if CEO visibility and philanthropy are authentic and focused on genuine community betterment. The survey found: 'These findings make it clear: The era of pragmatic philanthropy is here,' said Stacey Kennedy, CEO of PMI U.S. 'Americans are hungry for a new, grounded approach to ethical responsibility that's about listening to communities, investing locally, and showing up consistently.' When asked what makes a company a good neighbor, Americans overwhelmingly prioritize practical action over platitudes. Hiring locally and supporting small businesses (26%) and maintaining a consistent, visible presence in communities (23%) topped the list of valued practices. Meanwhile, 86% said the best way for a company to support a community is by offering stable, well-paying jobs. It's clear that Americans have little tolerance for performative-only philanthropy. Respondents ranked 'failing to listen' as the number one mistake companies make in community engagement, followed closely by 'doing it for PR.' They want companies to partner with local leaders, invest in jobs training, and build trust through sustained involvement, not one-off donations. The public holds complex views on business leadership. While 68% think CEOs should take public stands on key issues, a majority (58%) say they prefer not to know a CEO's political leanings. What matters more is visible involvement: CEOs who are active in their communities and empower their employees to give back earn the public's trust and support. Taken as a whole, the survey findings offer current guidance for PMI U.S. and other companies during a complex time for corporate leadership. 'It's clear that a deliberate approach of listening to learn is key,' said J.B. Simko, Chief Civil Society & Underage Prevention Officer at PMI U.S. 'Americans want to see partnerships that strengthen local communities and a shift from grand charity to shared responsibility and active collaboration. Corporate giving and engagement must focus more on tailored support and long-term partnerships that meaningfully address local needs – an approach we strive to take in the communities where we live and work.' As part of its mission to improve public health by offering science-backed, smoke-free products that are better alternatives to continued smoking, PMI U.S. is also committed to being a good neighbor in the communities where its people live and work. The company has invested more than $832 million in new and expanded manufacturing facilities in America that provide well-paying jobs, and its affiliates have contributed more than $25 million in worthy causes since 2022, prioritizing military veterans and their families, economic empowerment, and disaster preparedness and relief. About PMI For more information, please visit and References to 'PMI' mean the Philip Morris International family of companies. 'PMI U.S.,' 'we,' 'our,' and 'us' refer to PMI U.S. businesses. View source version on CONTACT: Philip Morris International PMI U.S. Communications Matt Sheaff +1 (203) 524-9146 [email protected] KEYWORD: UNITED STATES NORTH AMERICA CONNECTICUT INDUSTRY KEYWORD: RESEARCH TOBACCO PROFESSIONAL SERVICES PUBLIC POLICY/GOVERNMENT PHILANTHROPY OTHER PHILANTHROPY ENVIRONMENTAL, SOCIAL AND GOVERNANCE (ESG) RETAIL OTHER POLICY ISSUES SCIENCE SOURCE: Philip Morris International Inc. Copyright Business Wire 2025. PUB: 06/11/2025 09:30 AM/DISC: 06/11/2025 09:28 AM
Business Wire
12 hours ago
- Business
- Business Wire
Americans to Corporate America: Step Up, Get Local, and Lead with Your Values
STAMFORD, Conn.--(BUSINESS WIRE)--A groundbreaking new survey, 'Invested in America: Today's High Standards for U.S. Companies,' released today on behalf of Philip Morris International's U.S. businesses ('PMI U.S.'), reveals that the majority of Americans expect corporations to take a leading role in addressing community and societal challenges—favoring local impact. The PMI U.S. Philanthropy 2025 Benchmark Survey, conducted in April among 1,000 U.S. adults aged 21+, offers a portrait of a public that wants companies to go beyond business as usual. Companies are viewed as powerful and potentially better equipped than the government to drive change but only if CEO visibility and philanthropy are authentic and focused on genuine community betterment. The survey found: 84% of Americans believe big companies have an ethical responsibility to support the communities where they operate. 78% say they're more likely to buy from a brand that shares their values. 72% say corporations should help solve major systemic issues. 59% believe corporations may be better equipped than the government to tackle society's most pressing problems. 'These findings make it clear: The era of pragmatic philanthropy is here,' said Stacey Kennedy, CEO of PMI U.S. 'Americans are hungry for a new, grounded approach to ethical responsibility that's about listening to communities, investing locally, and showing up consistently.' When asked what makes a company a good neighbor, Americans overwhelmingly prioritize practical action over platitudes. Hiring locally and supporting small businesses (26%) and maintaining a consistent, visible presence in communities (23%) topped the list of valued practices. Meanwhile, 86% said the best way for a company to support a community is by offering stable, well-paying jobs. It's clear that Americans have little tolerance for performative-only philanthropy. Respondents ranked 'failing to listen' as the number one mistake companies make in community engagement, followed closely by 'doing it for PR.' They want companies to partner with local leaders, invest in jobs training, and build trust through sustained involvement, not one-off donations. The public holds complex views on business leadership. While 68% think CEOs should take public stands on key issues, a majority (58%) say they prefer not to know a CEO's political leanings. What matters more is visible involvement: CEOs who are active in their communities and empower their employees to give back earn the public's trust and support. Taken as a whole, the survey findings offer current guidance for PMI U.S. and other companies during a complex time for corporate leadership. 'It's clear that a deliberate approach of listening to learn is key,' said J.B. Simko, Chief Civil Society & Underage Prevention Officer at PMI U.S. 'Americans want to see partnerships that strengthen local communities and a shift from grand charity to shared responsibility and active collaboration. Corporate giving and engagement must focus more on tailored support and long-term partnerships that meaningfully address local needs – an approach we strive to take in the communities where we live and work.' As part of its mission to improve public health by offering science-backed, smoke-free products that are better alternatives to continued smoking, PMI U.S. is also committed to being a good neighbor in the communities where its people live and work. The company has invested more than $832 million in new and expanded manufacturing facilities in America that provide well-paying jobs, and its affiliates have contributed more than $25 million in worthy causes since 2022, prioritizing military veterans and their families, economic empowerment, and disaster preparedness and relief. Survey Methodology The PMI U.S. Philanthropy 2025 Survey was fielded by 3W Insights between April 22 and 27, 2025, among 1,000 U.S. adults 21 and older. The survey was conducted online using opt-in panel participants. The survey is representative of the U.S. population, based on known Census demographics and geographics. The margin of error for this survey is +/-3.1%, with higher margins of error for subgroups. Statistical testing was conducted at a 95% confidence level, and subgroup findings in this analysis are statistically significant at 95% confidence. About PMI Invested in America Philip Morris International Inc.'s U.S. businesses (collectively, 'PMI U.S.') are on a mission to improve public health in America by providing the ~30 million legal-age consumers who still smoke traditional cigarettes with better, smoke-free alternatives. PMI U.S. is committed to responsible marketing practices that help prevent access to its products by people under the age of 21. PMI U.S. businesses employ more than 2,500 people across America and operate product manufacturing facilities, including in Owensboro, Kentucky, and Wilson, North Carolina. Since 2022, PMI U.S. has contributed approximately $25 million to charitable causes, amplifying the good work of organizations already active within communities through financial contributions and volunteering. For more information, please visit and References to 'PMI' mean the Philip Morris International family of companies. 'PMI U.S.,' 'we,' 'our,' and 'us' refer to PMI U.S. businesses.
Yahoo
12 hours ago
- Business
- Yahoo
Americans to Corporate America: Step Up, Get Local, and Lead with Your Values
New PMI U.S. Survey Signals a Shift to an "Era of Pragmatic Philanthropy," as Public Seeks Community-First Leadership STAMFORD, Conn., June 11, 2025--(BUSINESS WIRE)--A groundbreaking new survey, "Invested in America: Today's High Standards for U.S. Companies," released today on behalf of Philip Morris International's U.S. businesses ("PMI U.S."), reveals that the majority of Americans expect corporations to take a leading role in addressing community and societal challenges—favoring local impact. The PMI U.S. Philanthropy 2025 Benchmark Survey, conducted in April among 1,000 U.S. adults aged 21+, offers a portrait of a public that wants companies to go beyond business as usual. Companies are viewed as powerful and potentially better equipped than the government to drive change but only if CEO visibility and philanthropy are authentic and focused on genuine community betterment. The survey found: 84% of Americans believe big companies have an ethical responsibility to support the communities where they operate. 78% say they're more likely to buy from a brand that shares their values. 72% say corporations should help solve major systemic issues. 59% believe corporations may be better equipped than the government to tackle society's most pressing problems. "These findings make it clear: The era of pragmatic philanthropy is here," said Stacey Kennedy, CEO of PMI U.S. "Americans are hungry for a new, grounded approach to ethical responsibility that's about listening to communities, investing locally, and showing up consistently." When asked what makes a company a good neighbor, Americans overwhelmingly prioritize practical action over platitudes. Hiring locally and supporting small businesses (26%) and maintaining a consistent, visible presence in communities (23%) topped the list of valued practices. Meanwhile, 86% said the best way for a company to support a community is by offering stable, well-paying jobs. It's clear that Americans have little tolerance for performative-only philanthropy. Respondents ranked "failing to listen" as the number one mistake companies make in community engagement, followed closely by "doing it for PR." They want companies to partner with local leaders, invest in jobs training, and build trust through sustained involvement, not one-off donations. The public holds complex views on business leadership. While 68% think CEOs should take public stands on key issues, a majority (58%) say they prefer not to know a CEO's political leanings. What matters more is visible involvement: CEOs who are active in their communities and empower their employees to give back earn the public's trust and support. Taken as a whole, the survey findings offer current guidance for PMI U.S. and other companies during a complex time for corporate leadership. "It's clear that a deliberate approach of listening to learn is key," said J.B. Simko, Chief Civil Society & Underage Prevention Officer at PMI U.S. "Americans want to see partnerships that strengthen local communities and a shift from grand charity to shared responsibility and active collaboration. Corporate giving and engagement must focus more on tailored support and long-term partnerships that meaningfully address local needs – an approach we strive to take in the communities where we live and work." As part of its mission to improve public health by offering science-backed, smoke-free products that are better alternatives to continued smoking, PMI U.S. is also committed to being a good neighbor in the communities where its people live and work. The company has invested more than $832 million in new and expanded manufacturing facilities in America that provide well-paying jobs, and its affiliates have contributed more than $25 million in worthy causes since 2022, prioritizing military veterans and their families, economic empowerment, and disaster preparedness and relief. Survey MethodologyThe PMI U.S. Philanthropy 2025 Survey was fielded by 3W Insights between April 22 and 27, 2025, among 1,000 U.S. adults 21 and older. The survey was conducted online using opt-in panel participants. The survey is representative of the U.S. population, based on known Census demographics and geographics. The margin of error for this survey is +/-3.1%, with higher margins of error for subgroups. Statistical testing was conducted at a 95% confidence level, and subgroup findings in this analysis are statistically significant at 95% confidence. About PMI Invested in AmericaPhilip Morris International Inc.'s U.S. businesses (collectively, "PMI U.S.") are on a mission to improve public health in America by providing the ~30 million legal-age consumers who still smoke traditional cigarettes with better, smoke-free alternatives. PMI U.S. is committed to responsible marketing practices that help prevent access to its products by people under the age of 21. PMI U.S. businesses employ more than 2,500 people across America and operate product manufacturing facilities, including in Owensboro, Kentucky, and Wilson, North Carolina. Since 2022, PMI U.S. has contributed approximately $25 million to charitable causes, amplifying the good work of organizations already active within communities through financial contributions and volunteering. For more information, please visit and References to "PMI" mean the Philip Morris International family of companies. "PMI U.S.," "we," "our," and "us" refer to PMI U.S. businesses. View source version on Contacts Philip Morris International PMI U.S. CommunicationsMatt Sheaff+1 (203) Sign in to access your portfolio
Yahoo
21-05-2025
- Health
- Yahoo
Two-Thirds of U.S. Healthcare Practitioners Mistakenly Believe or Are Unsure Whether Nicotine Causes Cancer, According to New Survey
Respondents want more FDA guidance on reduced-risk products to inform patient care WASHINGTON, May 21, 2025--(BUSINESS WIRE)--A new survey, funded by Philip Morris International's U.S. affiliates (PMI U.S.), has found that 47% of U.S. healthcare practitioners—rising to 59% among medical professionals who indicate that half or more of their patients smoke cigarettes—mistakenly believe nicotine is a carcinogen, despite scientific consensus that the harms of smoking primarily stem not from nicotine but from the burning of tobacco. Another 19% are unsure. Practitioners surveyed generally agree that smoke-free products—such as nicotine pouches and other noncombustible alternatives—are addictive and not risk-free, but still pose less risk than cigarettes. However, the survey results also show that misconceptions about nicotine persist and are obstructing progress on tobacco harm reduction. Povaddo LLC fielded the survey among 1,565 medical professionals, including physicians, nurses, and mental health practitioners, across the United States between March 10 and April 5, 2025. The survey results highlighted that: More than two-thirds of medical professionals want the U.S. Food and Drug Administration (FDA) to share clinical evidence that demonstrates the role of smoke-free products in harm reduction (69%) and clear guidance on counseling patients about transitioning to smoke-free alternatives as part of harm reduction strategies (68%). 95% would share FDA-provided information on smoke-free products with their patients. 77% of medical professionals believe addressing smoking and tobacco use should remain a "high priority" for the U.S. government. Despite decades of research as part of tobacco control efforts, misconceptions about nicotine are pervasive among healthcare professionals and others. The survey findings demonstrate an urgent need for healthcare regulators to provide unbiased, scientifically substantiated information about nicotine and nicotine products to the healthcare community. Many clinicians report uncertainty about which products are FDA-authorized and point to a lack of up-to-date information as barriers to more frequent and informed patient guidance regarding authorized smoke-free products. This is critical at a time when an estimated 480,000 Americans die each year from smoking-related illnesses. "Healthcare professionals are at the heart of patient care and need reliable, science-based information to help their patients make informed choices," said Stacey Kennedy, CEO of PMI U.S. "These findings reinforce the urgent need for transparent, evidence-driven communication from the FDA and other health authorities about the full spectrum of tobacco and nicotine products. We encourage the agency to provide timely, scientifically validated guidance to healthcare practitioners on FDA-authorized smoke-free alternatives. Ensuring clinicians have access to accurate information is essential to help adults 21+ who smoke make better choices and improve public health." This need for clear, science-based information is especially urgent given the survey's findings about persistent misconceptions within the medical community that may result in incomplete or inaccurate information being shared with patients. "One of the most striking findings from this research is the prevalence of misinformation about nicotine—even among otherwise well-informed healthcare professionals," said Matt Holman, vice president of U.S. scientific engagement and regulatory strategy at PMI U.S. and former director of the Office of Science at the FDA. "Addressing these misconceptions with robust, evidence-based communication from authorities like the FDA is crucial to helping providers guide their patients and support harm reduction." PMI has invested more than $14 billion globally in innovative smoke-free products and remains committed to giving adults 21+ access to FDA-authorized better alternatives. Read the full findings of the Tobacco Harm Reduction: U.S. Medical Professionals Survey (2025) here. Access PMI's science at and fact sheet on nicotine here. About PMI Philip Morris International Inc. is headquartered in Stamford, Connecticut, and its U.S. affiliates employ more than 2,500 people. PMI U.S. is on a mission to improve public health by providing the 45 million U.S. adults 21+ nicotine consumers—30 million of whom smoke cigarettes or use traditional tobacco—with innovative products that help them leave conventional cigarettes and other traditional tobacco products behind. Since 2008, PMI has invested more than $14 billion globally to develop and commercialize FDA-authorized smoke-free products for legal-age nicotine consumers. PMI U.S. operates smoke-free product manufacturing facilities, including Swedish Match North America's Owensboro, Kentucky, plant that makes ZYN nicotine pouches and a facility in Wilson, North Carolina, that produces HEETS for the IQOS heated tobacco device. Swedish Match North America has a regional office in Richmond, Virginia. U.S. marketing practices support 21+ access only PMI U.S. is committed to responsible marketing practices focused on limiting access to adults 21 years of age and older. PMI U.S. does not use social media influencers in the U.S. or people under the age of 35—or who appear to be under the age of 35—in marketing materials. PMI U.S. also employs independent age-verification systems, such as Double Verify, to direct digital advertising to those over 21, and owned digital platforms are age-gated at the point of access and restricted to current nicotine consumers who are 21+. Swedish Match North America is a Manufacturer Advisory Council member of the We Card Program, a national nonprofit serving retailers of age-restricted products. PMI is also a founding board member and investor in TruAge®, a free retail technology that provides stores with a more accurate method of age verification, including the ability to detect fake IDs, to ensure access is limited to those 21+. U.S. mission to improve public health through smoke-free products Because adult nicotine consumer preferences differ, PMI U.S. is working to offer a range of smoke-free options for adults 21+. Since 2008, PMI has invested over $14 billion to develop, scientifically substantiate and commercialize innovative smoke-free products. In 2022, PMI acquired Swedish Match—a leader in oral nicotine delivery—creating a global smoke-free champion led by the ZYN and IQOS brands. IQOS is authorized by the FDA as a modified risk tobacco product, meaning the FDA has found it appropriate for the promotion of public health. Although IQOS is not risk-free and is addictive, studies show that because the device heats tobacco instead of burning it, it significantly reduces the production of and exposure to harmful chemicals compared to conventional cigarettes for adults who smoke and who switch to IQOS completely. In 2025, the FDA authorized all 20 Swedish Match ZYN nicotine pouch products currently sold in the U.S., making ZYN the only FDA-authorized nicotine pouch on the market to help adults who use cigarettes or traditional tobacco products completely switch. The FDA has authorized Swedish Match's General snus as a modified risk tobacco product. Commitment to corporate social responsibility PMI U.S. has contributed approximately $25 million to charitable causes since 2022, amplifying the good work of organizations already active within communities through both financial contributions and volunteering. PMI's philanthropy pillars include supporting military veterans and military spouses, advancing local economic efforts in communities where PMI operates and natural disaster response and prevention. PMI U.S. helped form United to Safeguard America from Illegal Trade, a coalition of nearly 100 national and state brand enforcement experts, law enforcement agencies, academics and leading business organizations working to combat illegal trade. USA-IT has trained more than 36,000 law enforcement officials. For more information, please visit and References to "PMI" mean the Philip Morris International family of companies. "PMI U.S.," "we," "our," and "us" refer to PMI U.S. businesses. View source version on Contacts Philip Morris InternationalPMI U.S. CommunicationsMatt Sheaff+1 (203) Sign in to access your portfolio
Yahoo
21-05-2025
- Health
- Yahoo
Two-Thirds of U.S. Healthcare Practitioners Mistakenly Believe or Are Unsure Whether Nicotine Causes Cancer, According to New Survey
Respondents want more FDA guidance on reduced-risk products to inform patient care WASHINGTON, May 21, 2025--(BUSINESS WIRE)--A new survey, funded by Philip Morris International's U.S. affiliates (PMI U.S.), has found that 47% of U.S. healthcare practitioners—rising to 59% among medical professionals who indicate that half or more of their patients smoke cigarettes—mistakenly believe nicotine is a carcinogen, despite scientific consensus that the harms of smoking primarily stem not from nicotine but from the burning of tobacco. Another 19% are unsure. Practitioners surveyed generally agree that smoke-free products—such as nicotine pouches and other noncombustible alternatives—are addictive and not risk-free, but still pose less risk than cigarettes. However, the survey results also show that misconceptions about nicotine persist and are obstructing progress on tobacco harm reduction. Povaddo LLC fielded the survey among 1,565 medical professionals, including physicians, nurses, and mental health practitioners, across the United States between March 10 and April 5, 2025. The survey results highlighted that: More than two-thirds of medical professionals want the U.S. Food and Drug Administration (FDA) to share clinical evidence that demonstrates the role of smoke-free products in harm reduction (69%) and clear guidance on counseling patients about transitioning to smoke-free alternatives as part of harm reduction strategies (68%). 95% would share FDA-provided information on smoke-free products with their patients. 77% of medical professionals believe addressing smoking and tobacco use should remain a "high priority" for the U.S. government. Despite decades of research as part of tobacco control efforts, misconceptions about nicotine are pervasive among healthcare professionals and others. The survey findings demonstrate an urgent need for healthcare regulators to provide unbiased, scientifically substantiated information about nicotine and nicotine products to the healthcare community. Many clinicians report uncertainty about which products are FDA-authorized and point to a lack of up-to-date information as barriers to more frequent and informed patient guidance regarding authorized smoke-free products. This is critical at a time when an estimated 480,000 Americans die each year from smoking-related illnesses. "Healthcare professionals are at the heart of patient care and need reliable, science-based information to help their patients make informed choices," said Stacey Kennedy, CEO of PMI U.S. "These findings reinforce the urgent need for transparent, evidence-driven communication from the FDA and other health authorities about the full spectrum of tobacco and nicotine products. We encourage the agency to provide timely, scientifically validated guidance to healthcare practitioners on FDA-authorized smoke-free alternatives. Ensuring clinicians have access to accurate information is essential to help adults 21+ who smoke make better choices and improve public health." This need for clear, science-based information is especially urgent given the survey's findings about persistent misconceptions within the medical community that may result in incomplete or inaccurate information being shared with patients. "One of the most striking findings from this research is the prevalence of misinformation about nicotine—even among otherwise well-informed healthcare professionals," said Matt Holman, vice president of U.S. scientific engagement and regulatory strategy at PMI U.S. and former director of the Office of Science at the FDA. "Addressing these misconceptions with robust, evidence-based communication from authorities like the FDA is crucial to helping providers guide their patients and support harm reduction." PMI has invested more than $14 billion globally in innovative smoke-free products and remains committed to giving adults 21+ access to FDA-authorized better alternatives. Read the full findings of the Tobacco Harm Reduction: U.S. Medical Professionals Survey (2025) here. Access PMI's science at and fact sheet on nicotine here. About PMI Philip Morris International Inc. is headquartered in Stamford, Connecticut, and its U.S. affiliates employ more than 2,500 people. PMI U.S. is on a mission to improve public health by providing the 45 million U.S. adults 21+ nicotine consumers—30 million of whom smoke cigarettes or use traditional tobacco—with innovative products that help them leave conventional cigarettes and other traditional tobacco products behind. Since 2008, PMI has invested more than $14 billion globally to develop and commercialize FDA-authorized smoke-free products for legal-age nicotine consumers. PMI U.S. operates smoke-free product manufacturing facilities, including Swedish Match North America's Owensboro, Kentucky, plant that makes ZYN nicotine pouches and a facility in Wilson, North Carolina, that produces HEETS for the IQOS heated tobacco device. Swedish Match North America has a regional office in Richmond, Virginia. U.S. marketing practices support 21+ access only PMI U.S. is committed to responsible marketing practices focused on limiting access to adults 21 years of age and older. PMI U.S. does not use social media influencers in the U.S. or people under the age of 35—or who appear to be under the age of 35—in marketing materials. PMI U.S. also employs independent age-verification systems, such as Double Verify, to direct digital advertising to those over 21, and owned digital platforms are age-gated at the point of access and restricted to current nicotine consumers who are 21+. Swedish Match North America is a Manufacturer Advisory Council member of the We Card Program, a national nonprofit serving retailers of age-restricted products. PMI is also a founding board member and investor in TruAge®, a free retail technology that provides stores with a more accurate method of age verification, including the ability to detect fake IDs, to ensure access is limited to those 21+. U.S. mission to improve public health through smoke-free products Because adult nicotine consumer preferences differ, PMI U.S. is working to offer a range of smoke-free options for adults 21+. Since 2008, PMI has invested over $14 billion to develop, scientifically substantiate and commercialize innovative smoke-free products. In 2022, PMI acquired Swedish Match—a leader in oral nicotine delivery—creating a global smoke-free champion led by the ZYN and IQOS brands. IQOS is authorized by the FDA as a modified risk tobacco product, meaning the FDA has found it appropriate for the promotion of public health. Although IQOS is not risk-free and is addictive, studies show that because the device heats tobacco instead of burning it, it significantly reduces the production of and exposure to harmful chemicals compared to conventional cigarettes for adults who smoke and who switch to IQOS completely. In 2025, the FDA authorized all 20 Swedish Match ZYN nicotine pouch products currently sold in the U.S., making ZYN the only FDA-authorized nicotine pouch on the market to help adults who use cigarettes or traditional tobacco products completely switch. The FDA has authorized Swedish Match's General snus as a modified risk tobacco product. Commitment to corporate social responsibility PMI U.S. has contributed approximately $25 million to charitable causes since 2022, amplifying the good work of organizations already active within communities through both financial contributions and volunteering. PMI's philanthropy pillars include supporting military veterans and military spouses, advancing local economic efforts in communities where PMI operates and natural disaster response and prevention. PMI U.S. helped form United to Safeguard America from Illegal Trade, a coalition of nearly 100 national and state brand enforcement experts, law enforcement agencies, academics and leading business organizations working to combat illegal trade. USA-IT has trained more than 36,000 law enforcement officials. For more information, please visit and References to "PMI" mean the Philip Morris International family of companies. "PMI U.S.," "we," "our," and "us" refer to PMI U.S. businesses. View source version on Contacts Philip Morris InternationalPMI U.S. CommunicationsMatt Sheaff+1 (203) Sign in to access your portfolio
